These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21418093)

  • 21. Do low-risk prenatal patients really need a screening glucose challenge test?
    Helton MR; Arndt J; Kebede M; King M
    J Fam Pract; 1997 Jun; 44(6):556-61. PubMed ID: 9191628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendations.
    Coop C; Edlin R; Brown J; Farquhar C
    BMJ Open; 2015 Jun; 5(6):e006996. PubMed ID: 26100024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of two routine screening strategies for gestational diabetes mellitus: the experience of Jean-Verdier Hospital].
    Benchimol M; Cosson E; Faure C; Carbillon L; Attali R; Uzan M
    Gynecol Obstet Fertil; 2006 Feb; 34(2):107-14. PubMed ID: 16442325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for gestational diabetes mellitus in pregnant females.
    Ardawi MS; Nasrat HA; Jamal HS; Al-Sagaaf HM; Mustafa BE
    Saudi Med J; 2000 Feb; 21(2):155-60. PubMed ID: 11533772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal screening of gestational diabetes mellitus: prevalence and diagnostic value of clinical risk factors.
    Arora D; Arora R; Sangthong S; Leelaporn W; Sangratanathongchai J
    J Med Assoc Thai; 2013 Mar; 96(3):266-71. PubMed ID: 23539927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gestational diabetes in a tertiary care hospital: implications of applying the IADPSG criteria.
    Agarwal MM; Dhatt GS; Othman Y
    Arch Gynecol Obstet; 2012 Aug; 286(2):373-8. PubMed ID: 22484479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of travel distance on the decision to attend for screening for gestational diabetes mellitus.
    Cullinan J; Gillespie P; Owens L; Dunne FP;
    Ir Med J; 2012 May; 105(5 Suppl):18-20. PubMed ID: 22838103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feto-maternal outcomes in women with and without gestational diabetes mellitus according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria.
    Nayak PK; Mitra S; Sahoo JP; Daniel M; Mathew A; Padma A
    Diabetes Metab Syndr; 2013; 7(4):206-9. PubMed ID: 24290085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective rather than universal screening for gestational diabetes mellitus?
    Miailhe G; Kayem G; Girard G; Legardeur H; Mandelbrot L
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():95-100. PubMed ID: 26112365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a socioeconomic gradient in the prevalence of gestational diabetes mellitus?
    Cullinan J; Gillespie P; Owens L; Avalos G; Dunne FP;
    Ir Med J; 2012 May; 105(5 Suppl):21-3. PubMed ID: 22838104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational diabetes mellitus screening, management and outcomes in the Cook Islands.
    Aung YY; Sowter M; Kenealy T; Herman J; Ekeroma A
    N Z Med J; 2015 Apr; 128(1412):21-8. PubMed ID: 25899489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gestational diabetes guidelines in a HAPO world.
    Leary J; Pettitt DJ; Jovanovic L
    Best Pract Res Clin Endocrinol Metab; 2010 Aug; 24(4):673-85. PubMed ID: 20832745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral glucose tolerance testing at gestational weeks < or =16 could predict or exclude subsequent gestational diabetes mellitus during the current pregnancy in high risk group.
    Bitó T; Nyári T; Kovács L; Pál A
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):51-5. PubMed ID: 15989984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost of screening for gestational diabetes mellitus.
    Wilson N; Ashawesh K; Smith S; Anwar A
    J Med Screen; 2008; 15(4):213. PubMed ID: 19106264
    [No Abstract]   [Full Text] [Related]  

  • 35. The birth of ATLANTIC DIP: an overview.
    Dunne FP; Gaffney G;
    Ir Med J; 2012 May; 105(5 Suppl):2-4. PubMed ID: 22838096
    [No Abstract]   [Full Text] [Related]  

  • 36. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis.
    Mission JF; Ohno MS; Cheng YW; Caughey AB
    Am J Obstet Gynecol; 2012 Oct; 207(4):326.e1-9. PubMed ID: 22840972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasting plasma glucose versus glucose challenge test: screening for gestational diabetes and cost effectiveness.
    Rey E; Hudon L; Michon N; Boucher P; Ethier J; Saint-Louis P
    Clin Biochem; 2004 Sep; 37(9):780-4. PubMed ID: 15329316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How should we screen for gestational diabetes?
    Petrović O
    Curr Opin Obstet Gynecol; 2014 Apr; 26(2):54-60. PubMed ID: 24614019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease.
    Round JA; Jacklin P; Fraser RB; Hughes RG; Mugglestone MA; Holt RI
    Diabetologia; 2011 Feb; 54(2):256-63. PubMed ID: 20809381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATLANTIC-DIP: excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus.
    Egan AM; Dennedy MC; Al-Ramli W; Heerey A; Avalos G; Dunne F
    J Clin Endocrinol Metab; 2014 Jan; 99(1):212-9. PubMed ID: 24187402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.